TrialJMA journal2026

Triplet Therapy (Androgen Deprivation Therapy + Darolutamide + Biweekly Docetaxel) for High-risk Metastatic Castration-sensitive Prostate Cancer (TRIC Study): A Study Protocol for Open-labelled Single-Arm Phase II Clinical Trial.

Hiroaki Iwamoto et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.